GPhA to super committee: Don’t ban patent settlements
Echoing what it calls a "growing chorus of policymakers," the Generic Pharmaceutical Association (GPhA) has urged the congressional "super committee" on deficit reduction to nix a proposed legislative ban on pharmaceutical patent settlements.